Digitalist Group Oyj
29.12.2025 14:32:06 CET | Globenewswire | Press release
Digitalist Group Oyj - Managers' Transactions
Digitalist Group Oyj - Managers' Transactions
Digitalist Group Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Wilhelm Rosenlew
Position: Member of the Board/Deputy member
Issuer: Digitalist Group Oyj
LEI: 743700AL68PUX6JMS644
Notification type: INITIAL NOTIFICATION
Reference number: 135489/5/4
____________________________________________
Transaction date: 2025-12-18
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000591698
Nature of transaction: DISPOSAL
Transaction details
(1): Volume: 750 Unit price: 2.64 EUR
(2): Volume: 2500 Unit price: 2.62 EUR
(3): Volume: 2000 Unit price: 2.57 EUR
Aggregated transactions (3):
Volume: 5250 Volume weighted average price: 2.60381 EUR
Digitalist Group Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Wilhelm Rosenlew
Position: Member of the Board/Deputy member
Issuer: Digitalist Group Oyj
LEI: 743700AL68PUX6JMS644
Notification type: INITIAL NOTIFICATION
Reference number: 135492/5/4
____________________________________________
Transaction date: 2025-12-19
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000591698
Nature of transaction: DISPOSAL
Transaction details
(1): Volume: 6000 Unit price: 2.51 EUR
Aggregated transactions (1):
Volume: 6000 Volume weighted average price: 2.51 EUR
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
Lakefront Receives Transparency Notification from Bank of America
Lakefront Biotherapeutics24.8.2026 22:01:00 CEST | Press release
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
Cosmos Health Inc.24.8.2026 21:40:00 CEST | Press release
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
Kitron ASA24.8.2026 17:07:52 CEST | Press release
Kitron revises full-year 2026 outlook upwards
Zealand Pharma24.8.2026 17:05:00 CEST | Press release
Zealand Pharma – Notification of holding of treasury shares
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom